Company Profile

Member Since

  • 2018

Membership Category

  • Pharmaceutical Sales and Mfg

Contact Information

South San Francisco, CA 94080
United States


  • Our novel Probody Platform allows us to design drugs that selectively activate in the tumor microenvironment while reducing drug activity in healthy tissue and in circulation. This unique ability to localize therapeutic effects to the tumor reduces systemic toxicity, with potential for safer and more effective therapies for a broad array of validated and previously inaccessible oncology targets. Driven by a vision to transform patient lives, we are advancing multiple Probody cancer immunotherapies and Probody drug conjugates toward clinical investigation, while also applying our technology to bispecific T-cell engaging antibodies and ProCAR-NK cell therapies.

Number of Employees

  • 50 - 499